Condensed Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash flows from operating activities:
Net income / (loss)	$ 1,000	$ (45,000)
Adjustments to reconcile net income / (loss) to net cash provided by operating activities:
Depreciation and amortization	23,000	25,000
Loss on disposal of fixed assets	0	3,000
Amortization of deferred finance and debt discount	27,000	42,000
Provision for bad debts	0	(2,000)
Provision for slow moving and obsolete inventory	21,000	21,000
Share-based payment expense	19,000	11,000
Changes in:
Accounts receivable	(117,000)	168,000
Inventory	104,000	(111,000)
Prepaid expenses and other current assets	(2,000)	32,000
Accounts payable	98,000	13,000
Accrued expenses and other current liabilities	2,000	(18,000)
Wages payable	(5,000)	38,000
Net cash provided by operating activities	172,000	177,000
Cash flows from investing activities:
Patent application costs	(3,000)	(2,000)
Net cash (used in) investing activities	(3,000)	(2,000)
Cash flows from financing activities:
Proceeds (payments) on debt financing	(75,000)	(1,071,000)
Proceeds from refinance	0	1,200,000
Deferred finance costs	0	(111,000)
Proceeds from lines of credit	1,513,000	1,316,000
Payments on lines of credit	(1,669,000)	(1,374,000)
Net cash (used in) financing activities	(231,000)	(40,000)
Net Increase / (decrease) in cash and cash equivalents	(61,000)	135,000
Cash and cash equivalents - beginning of period	158,000	352,000
Cash and cash equivalents - end of period	97,000	487,000
Supplemental disclosures of cash flow information
Cash paid during period for interest	39,000	65,000
Cash paid during period for taxes	0	0
Consulting expense prepaid with restricted stock	49,000	0
Debt issuance cost paid with restricted stock	$ 96,000	$ 0